Recombinant antigens
ospC
for Borrelia garinii, Borrelia afzelii and Borrelia burgdorferi
Outer membrane protein ospC is essential for the invasive strategy of the pathogenic spirochete responsible for Lyme disease. Detection of anti-OspC borreliacidal antibodies, especially IgM antibodies, in early Lyme borreliosis sera provides additional evidence that borreliacidal antibody detection may be useful for the serodiagnosis of early Lyme borreliosis.
- NAME
- Ospc
- DESCRIPTION
- Outer membrane antigen
- GEN
- ospC
- PURITY
- >95% by observation on SDS-PAGE electrophoresis
- Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk.
*under availability, for liquid format
* Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. In addition, we follow a rigorous quality control for each lot.
References of Recombinant antigen ospC
Folletos
- Rekom Biotech catalogue
- Recombinant proteins for in vitro diagnosis of human infectious diseases
- Recombinant proteins for in vitro diagnosis of animal infectious diseases
- Farm animal infectious diseases
- Recombinant proteins for vector-borne diseases
- Recombinant antigens for diagnosis of Lyme
Videos
- How to reconsitute lyophizated vials
- Recombinant antigens for the diagnosis of Lyme disease (Lyme borreliosis)
Related proteins
Reagent sheet
- NAME
- ospC
- DESCRIPTION
- Outer membrane antigen
- PURITY
- >95% by observation on SDS-PAGE electrophoresis
- Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk.
*under availability, for liquid format
* Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. In addition, we follow a rigorous quality control for each lot.